mesalamine has been researched along with Tuberculosis, Splenic in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Tuberculosis, Splenic: Infection of the spleen with species of MYCOBACTERIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dussouillez, G | 1 |
| Zayet, S | 1 |
| Kone, D | 1 |
| Royer, PY | 1 |
| Toko-Tchuindzie, L | 1 |
| Ruyer, O | 1 |
| Gendrin, V | 1 |
1 other study available for mesalamine and Tuberculosis, Splenic
| Article | Year |
|---|---|
[Tuberculous liver abscess, anti-TNF alpha, and immune reconstitution inflammatory syndrome].
Topics: Adalimumab; Adult; Antirheumatic Agents; Antitubercular Agents; Drug Substitution; Drug Therapy, Com | 2020 |